|
Volumn 8, Issue 3, 2002, Pages 133-136
|
Streptococcal toxic shock syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
BACTERIAL TOXIN;
BACTERIUM LIPOPOLYSACCHARIDE;
BETA LACTAM ANTIBIOTIC;
CLINDAMYCIN;
CYTOKINE;
IMMUNOGLOBULIN;
M PROTEIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PENICILLIN G;
PROTEIN ANTIBODY;
TOXIC SHOCK SYNDROME TOXIN 1;
TUMOR NECROSIS FACTOR;
BACTEREMIA;
BACTERIAL STRAIN;
CLOSTRIDIUM PERFRINGENS;
CONTROLLED STUDY;
DRUG EFFICACY;
EARLY DIAGNOSIS;
EDITORIAL;
GEOGRAPHY;
HUMAN;
INCIDENCE;
MORBIDITY;
MORTALITY;
NONHUMAN;
PHARYNGITIS;
PRIORITY JOURNAL;
SCARLET FEVER;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS;
STREPTOCOCCUS GROUP A;
TISSUE NECROSIS;
TOXIC SHOCK SYNDROME;
TREATMENT PLANNING;
BACTERIA (MICROORGANISMS);
CLOSTRIDIUM;
CLOSTRIDIUM PERFRINGENS;
STAPHYLOCOCCUS;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS;
STREPTOCOCCUS SP. 'GROUP A';
|
EID: 0036489742
PISSN: 1198743X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1469-0691.2002.00387.x Document Type: Editorial |
Times cited : (32)
|
References (16)
|